Connect with us

Technology

ADC Therapeutics Announces New Employee Inducement Grant

Published

on

LAUSANNE, Switzerland, Nov. 2, 2026 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made a grant of options to purchase an aggregate of 17,000 of the Company’s common shares to a new employee on November 2, 2026. (“Grant”).

The Grant was offered as material inducement to the employee’s employment. The Grant was approved by the Compensation Committee of the Company’s Board of Directors pursuant to the Company’s Inducement Plan to motivate and reward the recipients to perform at the highest levels and contribute significantly to the success of the Company. The Grant was made in reliance on the employment inducement exemption under the NYSE’s Listed Company Manual Rule 303A.08.

The Company is issuing this press release pursuant to Rule 303A.08. The Grant shall vest and become exercisable 25% on the first anniversary of the grant date, and 1/48th of the aggregate number of shares subject to the award on each monthly anniversary of the grant date thereafter, such that the entire award will be vested as of the fourth anniversary of the grant date, subject to continued employment with the Company.

About ADC Therapeutics
ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), transforming treatment for patients through our focused portfolio with ZYNLONTA® (loncastuximab tesirine-lpyl).

ADC Therapeutics’ CD19-directed ADC ZYNLONTA received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy.

Headquartered in Lausanne (Biopôle), Switzerland, with operations in New Jersey, ADC Therapeutics is focused on driving innovation in ADC development with specialized capabilities from clinical to manufacturing and commercialization. Learn more at adctherapeutics.com and follow us on LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “would”, “expect”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “future”, “continue”, or “appear” or the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to: whether Tanabe’s marketing authorization application filed with Japan’s Ministry of Health for ZYNLONTA will be accepted, the timing and potential approval of the marketing authorization application for ZYNLONTA in Japan, the timing and payment of future regulatory and commercial milestones related to Japan, Nippon Shinyaku ability to successfully commercialize ZYNLONTA in Japan and the amount of future revenue in Japan and related payments to ADCT; the adequacy of the LOTIS-5 clinical trial data to support full regulatory approval and our ability to maintain accelerated approval in the United States and foreign jurisdictions for our product; our ability to identify and execute on potential regulatory and compendia pathways; the timing, content and outcome of meetings with and feedback or other communications provided by regulatory authorities including U.S. FDA including our ability to adequately address the serious concerns related to the LOTIS-5 trial results raised by the FDA at the recent pre-sBLA submission meeting; the timing, submission and outcome of an sBLA related to LOTIS-5 and potential approval; the actual and perceived benefit-risk profile for ZYNLONTA as studied in the LOTIS-5 trial; the assessment of the data from LOTIS-5 study, including additional analyses of outcomes observed for safety, efficacy and within key geographic regions and across certain patient sub-populations; the path for full regulatory approval for ZYNLONTA in the United States and foreign jurisdictions and into earlier lines of therapy; whether future LOTIS-7 results will be consistent with or different from the prior disclosure, the timing, results and publication of the full LOTIS-7 trial data and potential compendia inclusion; future regulatory strategy for a Phase 3 trial for the combination of ZYNLONTA plus glofitamab; our expected revenue growth in 2027 and the Company’s ability to sustain or grow ZYNLONTA® revenue in the future; our expected cash runway into 2029; changes in our regulatory and commercial strategy; the ability of our partners to commercialize ZYNLONTA® in foreign markets, the timing and amount of future revenue and payments to us from such partnerships and their ability to obtain or maintain regulatory approval for ZYNLONTA® in foreign jurisdictions; the timing and results of the Company’s clinical trials; the timing, publication and results of investigator-initiated trials including those studying FL and MZL and the potential regulatory and/or compendia strategy and the future opportunity; the timing and outcome of regulatory submissions for the Company’s products or product candidates; actions by the FDA or foreign regulatory authorities; projected revenue and expenses; the Company’s indebtedness, including HealthCare Royalty Management and Blue Owl and Oaktree facilities, and the restrictions imposed on the Company’s activities by such indebtedness, the ability to comply with the terms of the various agreements and repay such indebtedness and the significant cash required to service such indebtedness; the Company’s ability to obtain financial and other resources for its research, development, clinical, and commercial activities; uncertainties related to a potential change in domicile from Switzerland to Delaware, including the outcome of tax analyses associated with such redomiciliation, the receipt of requisite shareholder approval, and the ability to complete the redomiciliation on the anticipated terms and timeline, if at all; and the uncertainties of international trade policies, including tariffs, sanctions, trade barriers and most favored nation drug pricing and the potential impact they may have on our business, financial condition, and results of operations. Additional information concerning these and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements is contained in the “Risk Factors” section of the Company’s Annual Report on Form 10-K and in the Company’s other periodic and current reports and filings with the U.S. Securities and Exchange Commission. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document.

CONTACTS:
Investors and Media
Nicole Riley
ADC Therapeutics
Nicole.Riley@adctherapeutics.com
+1 862-926-9040

View original content to download multimedia:https://www.prnewswire.com/news-releases/adc-therapeutics-announces-new-employee-inducement-grant-302925153.html

SOURCE ADC Therapeutics SA

Continue Reading

Technology

Bridge Alliance API Exchange (BAEx) Accelerates Regional Network API Adoption with Early Enterprise Customers and Market Expansion

Published

on

By

SINGAPORE, Nov. 3, 2026 /PRNewswire/ — Bridge Alliance, the leading mobile alliance for operators globally, today announced the commercial realisation of regional network APIs through early enterprise customers via the Bridge Alliance API Exchange (BAEx). Companies from the cloud services, mobile gaming and fintech sectors are leveraging network APIs through BAEx to power diverse digital services, demonstrating the growing commercial potential of operator network capabilities across the region.

Number Verify is one of the first APIs adopted by the companies. Number Verify confirms that the phone number a user provides is the same one they are using to access an online service or app. With digital fraud and scams a growing concern in Asia-Pacific, silent network authentication APIs such as Number Verify could authenticate users and enable service providers to build greater consumer trust. These initial deployments are intended as a foundation: as the commercial pilots progress, several of the enterprise customers will evaluate additional BAEx APIs, built on GSMA Open Gateway and CAMARA standards, and telco signals for identity verification and fraud detection.

Mr Loo Boon Chee, CEO of Bridge Alliance, said, “We warmly welcome our new BAEx customers and partners!  There has been a lot of pent-up demand and clear use cases for APIs among enterprises. We’ve worked hard to bring API capabilities together in a single platform that enables them consistent access, backed by our commercial model packaged and priced to market needs. BAEx has thus turned network API potential into a commercial reality, closing the network API demand and supply gap. We look forward to having more enterprise customers on board as we continue to add to the APIs available on BAEx.”

Mr Max Wang, Head of Cloud Communication International Business Operations, Alibaba Cloud, said, “In the era of AI, secure identity is paramount. Just as Alibaba Cloud championed Number Verify in China, Bridge Alliance now leads its adoption across APAC. As one of the original signatories with GSMA to champion this technology, we firmly believe it will eliminate mobile authentication friction and combat artificially inflated SMS traffic. By advancing Number Verify and the broader CAMARA framework, we empower enterprises to deliver seamless, trusted, and efficient digital services.”

New channel partners on board

Meanwhile, Bridge Alliance has inked strategic partnership agreements with new BAEx partners MX Labs, SBTS and TMT ID. These channel partners will connect more enterprise customers to BAEx in the coming months. MX Labs, a Singapore-based messaging infrastructure provider, brings an established enterprise base ready to move beyond SMS-based verification. SBTS, a SoftBank subsidiary, brings extensive identity and fraud detection capabilities. TMT ID, a specialist in network intelligence, uses network APIs to support identity verification and frictionless onboarding.

Mr Xinkai Chua, Managing Director of MX Labs, said, “BAEx gives us a single integration into Bridge Alliance’s member operators, so we can bring network-based number verification to our customers across Asia without building market by market. Silent verification over the mobile network cuts sign-up friction and fraud, and reduces reliance on SMS one-time passwords. We look forward to growing with BAEx as more markets and APIs come live.”

Mr John Tolton, Senior Vice President, Strategic Business Development, SBTS, said, “At SBTS, our ambition is to bring the value of the network closer to the enterprise, turning network intelligence into solutions that address real challenges in identity, trust and fraud prevention. BAEx brings us closer to that goal, creating a path to scale these solutions and make network intelligence an integral part of the digital customer journey.”

Mr Fergal Parkinson, CMO and Co-Founder of TMT ID, said: “We are delighted to collaborate with Bridge Alliance, which provides us the regional infrastructure to scale, ensuring our clients can verify genuine users and block high-risk interactions in milliseconds. By joining forces, we are expanding our operational footprint across Asia, enabling us to deliver secure, frictionless identity verification to enterprises, developers, and leading social media platforms in the region.”

BAEx Partner Programme welcomes Proximus Global

Bridge Alliance also welcomes Proximus Global, a subsidiary of Proximus, to the BAEx Partner Programme. Drawing on its distinct international experience, Proximus Global will share valuable lessons and expertise with fellow participants in technical workstreams. The Programme’s continued expansion and valuable insights from a wide spectrum of members and markets supports greater API innovation, development and standardisation, and market readiness across the region.

New markets, new APIs, new possibilities

BAEx is now expanding its presence to India and the Philippines, in addition to Indonesia, Malaysia, Taiwan and Thailand which Bridge Alliance lighted up in November 2025. API availability in these two new markets will enable proofs of concept and the development of new digital services in the coming months. Singapore and Vietnam will follow in the first quarter of 2027, extending BAEx coverage across most of Southeast Asia.

Meanwhile, Bridge Alliance’s collaboration with Aduna Global is also accelerating  global access to APIs. The combined coverage of BAEx and Aduna enables both organisations’ partners across North America, Europe and Asia to consume network APIs with ease.  Bridge Alliance and Aduna are jointly organising the inaugural Global API Forum in Singapore on 3 November 2026. The event brings together over 300 operators, developers, solution providers, and enterprise customers to discuss the challenges, opportunities, and real-world applications of API adoption.

BAEx already offers silent network authentication APIs such as Number Verify and SIM Swap, which enable secure and seamless verification. By 4Q2026, BAEx will add Know-Your-Customer (KYC) APIs to its portfolio, including KYC Match, KYC Age, KYC Tenure and Number Recycling, which verify user details against operator records. These APIs will add trust and security to digital transactions, helping enterprises prevent mule accounts and seamlessly verify delivery and marketing data.

Enterprises interested to learn more about BAEx can contact Bridge Alliance here: https://www.bridgealliance.com/how_we_help/baex-enterprises/

About Bridge Alliance

Bridge Alliance is the global collective of premier mobile operators, representing nearly 2 billion customers across the world’s most dynamic markets. Founded in 2004, we drive deep strategic collaboration between leading operators and technology partners to unlock enterprise growth. By leveraging group economies and shared innovation, we empower our ecosystem to lead, scale, and thrive in the digital and AI era. 

Visit www.bridgealliance.com for more information. 

View original content:https://www.prnewswire.com/apac/news-releases/bridge-alliance-api-exchange-baex-accelerates-regional-network-api-adoption-with-early-enterprise-customers-and-market-expansion-302927357.html

SOURCE Bridge Alliance

Continue Reading

Technology

XTransfer and Bank of China (Hong Kong) Announce Partnership at Hong Kong FinTech Week

Published

on

By

Empowering Global Collections and Payments for Foreign Trade Enterprises

HONG KONG, Nov. 3, 2026 /PRNewswire/ — XTransfer, the world’s leading B2B cross-border trade payment platform, and Bank of China (Hong Kong) (“BOCHK”) are pleased to announce the signing of a cooperation agreement. The two parties will work together to expand their international business, providing one-stop cross-border financial services, including global collections, payments, and foreign exchange, for enterprises engaged in international trade in Hong Kong and around the world.

Coinciding with Hong Kong FinTech Week 2026, Mr Martin Liu, Vice President of XTransfer and Ms Winnie Fan, Deputy General Manager of the Global Corporate Banking Department of BOCHK, officially signed the cooperation agreement at the XTransfer booth, witnessed by Mr Bill Deng, Founder and CEO of XTransfer and Mr Liu Chao, General Manager of the Global Corporate Banking Department of BOCHK, marking a new stage in the partnership between the two parties.

Under this cooperation, XTransfer and BOCHK will collaborate in depth across business areas including global collections, payments, and foreign exchange. Leveraging BOCHK’s professional capabilities in cross-border settlement and foreign exchange trading, as well as its unique position as the RMB clearing bank in Hong Kong, combined with XTransfer’s self-built globally unified B2B cross-border settlement network and risk management system, the two parties will jointly create an efficient, lower-cost, and compliant fund collection, payment, and currency exchange experience for foreign trade enterprises. Under this cooperation model, XTransfer is the first corporate partner of BOCHK.

As the cooperation progresses, foreign trade enterprises in Hong Kong and around the world will be able to access global cross-border collection, payment, and foreign exchange services more conveniently, meeting their multi-currency transaction and settlement needs across different markets. Both parties expect that by reducing the handover points in cross-border transaction processes, they can enhance the service experience and capital turnover efficiency, helping enterprises seize global trade opportunities more flexibly.

This cooperation also reflects XTransfer’s continuously deepening Financial Institution Partnership Model. Financial institution partners can act as “Co-builders”, providing cross-border collection, payment, and foreign exchange capabilities; at the same time, through XTransfer’s network covering over one million business customers, they can reach more enterprise customer segments with cross-border financial service needs, achieving complementary capabilities and shared strengths.

Mr Bill Deng, Founder and CEO of XTransfer, said, “We are very honored to sign the cooperation agreement with BOCHK during Hong Kong FinTech Week. BOCHK is one of Hong Kong’s most representative banks, with deep expertise in cross-border settlement and foreign exchange services. This cooperation combines the strengths of both parties, enabling SMEs to enjoy cross-border financial services of the same standard as large multinational corporations. Going forward, we will continue to refine our compliance and risk control capabilities and work with more financial institution partners to build trustworthy cross-border financial infrastructure.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/xtransfer-and-bank-of-china-hong-kong-announce-partnership-at-hong-kong-fintech-week-302927362.html

SOURCE XTransfer

Continue Reading

Technology

PATEO Advances In-Vehicle AI with NVIDIA Nemotron and ByteDance Doubao on its AI Box built on NVIDIA DRIVE AGX Thor

Published

on

By

SHANGHAI, Nov. 3, 2026 /PRNewswire/ — PATEO is advancing in-vehicle AI by deploying NVIDIA Nemotron and the 35-billion-parameter ByteDance Doubao language model in its AI Box, built on NVIDIA DRIVE AGX Thor. The solution combines local AI inference with PATEO’s AI Agent platform to support multilingual interaction, understand cabin context and coordinate vehicle functions.

At Auto China 2026 in Beijing, PATEO announced joint development of the solution with ByteDance and a leading new energy vehicle automaker. PATEO has also secured a project nomination for a new-generation vehicle from a leading new energy vehicle automaker, with mass production for that program expected in the second quarter of 2027.

In-vehicle local inference with Nemotron and Doubao

PATEO has integrated NVIDIA Nemotron 3.5 ASR for speech recognition into its in-vehicle model suite. In collaboration with ByteDance, PATEO has also integrated Doubao, a 35-billion-parameter mixture-of-experts language model. The suite includes text-to-speech synthesis and a 2-billion-parameter language model for semantic classification and request rejection.

The integrated suite can run inference locally without a cloud connection, supporting multilingual voice interaction and real-time streaming speech recognition. This enables core AI functions to remain available when connectivity is limited, while connected services and cloud updates extend the system’s capabilities.

The PATEO AI Agent platform combines voice, visual and sensor inputs to interpret user requests and cabin conditions. Within vehicle safety permissions, it can invoke cabin controls and online services, coordinate concurrent tasks and manage longer-running requests. With user authorization, it can remember preferences and habits to personalize future interactions.

AI Box Brings Proactive Intelligence to the Cockpit

PATEO’s AI Box supports practical scenarios throughout the driving experience. Sentinel AI can identify and issue alerts for risks such as parking violations, flooding and fire. On hot commutes, occupants can independently adjust driver and passenger climate settings through voice commands or gestures. During extended highway driving, the AI agent can detect driver fatigue and ask whether the driver would like to open a window or activate seat massage. In areas with poor air quality, it can suggest closing windows and switching to recirculation based on location and learned driving habits.

Built on NVIDIA DRIVE AGX Thor, the AI Box connects perception, reasoning, execution and learning. Sustaining these experiences requires memory bandwidth alongside peak compute measured in TOPS. As context accumulates across conversation turns and agent actions during a trip, the model’s key-value (KV) cache grows, increasing demands on memory capacity and bandwidth. Thor’s accelerated compute and high memory bandwidth help support responsive local inference. Within automotive safety permissions, the AI Box coordinates cockpit controls, connected services and concurrent or longer-running tasks. With user authorization, it remembers preferences and habits, while cloud updates help refine its capabilities.

The AI Box’s modular software architecture and integration with in-vehicle systems and NVIDIA’s edge and cloud AI ecosystem support model deployment, tuning and customization across vehicle programs. By adding dedicated AI computing capacity without replacing the original main control chip, it also offers an upgrade path for existing vehicles whose processors cannot support larger models, concurrent multimodal interactions and proactive agents through software updates alone.

Expanding Beyond Hardware with Tokenomics and Physical AI

PATEO is building on the AI Box to expand from one-time hardware delivery into ongoing AI services and operations. Its in-vehicle Tokenomics strategy aims to create recurring revenue around the deployment and use of AI capabilities, extending the business opportunity beyond the initial hardware sale.

In June 2026, PATEO formed partnerships with Mininglamp Technology, Xunce Technology and Saimo Technology to jointly develop a token-based physical AI world model and TokenOS. The collaboration brings together on-device hardware, simulation testing, data infrastructure, creating a foundation for delivering and operating AI services.

Built on NVIDIA DRIVE AGX Thor, the AI Box provides a reusable platform that PATEO can adapt to different automakers and vehicle programs. The company is also extending its expertise in intelligent interaction and hardware engineering into robotics. PATEO reports a project nomination from a leading domestic robotics computing provider, opening an opportunity to apply its platform capabilities to physical AI applications beyond vehicles.

As on-device models and AI agents move toward broader automotive deployment, PATEO is combining NVIDIA accelerated computing with its cockpit software and hardware expertise to support that transition. Its focus on reusable technology, deployment across vehicle programs and ongoing AI services supports its evolution from a smart cockpit supplier into an AI platform company, with opportunities for growth across automotive and broader physical AI markets.

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/pateo-advances-in-vehicle-ai-with-nvidia-nemotron-and-bytedance-doubao-on-its-ai-box-built-on-nvidia-drive-agx-thor-302927306.html

SOURCE PATEO

Continue Reading

Trending